2,5-disubstituted piperidine orexin receptor antagonists

Details for Australian Patent Application No. 2009307915 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Cox, Christopher D.; Coleman, Paul J.; Breslin, Michael J.; Raheem, Izzat T.; Schreier, John D.; Roecker, Anthony J.

Agent Spruson & Ferguson

Pub. Number AU-A-2009307915

PCT Pub. Number WO2010/048012

Priority 61/196,850 21.10.08 US

Filing date 15 October 2009

Wipo publication date 29 April 2010

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/048012 Priority application(s): WO2010/048012

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009307916-2,5-disubstituted morpholine orexin receptor antagonists

2009307913-2,5-disubstituted piperidine orexin receptor antagonists